These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 5000657

  • 1. [Early results of ethambutol treatment in patients with cavernous pulmonary tuberculosis and resistance to many antitubercular agents].
    Kamińska M, Czajka-Kropaczek L, Ciechanowska A.
    Gruzlica; 1971 Jul; 39(7):648-52. PubMed ID: 5000657
    [No Abstract] [Full Text] [Related]

  • 2. [Effectiveness of ethambutol in chronic pulmonary tuberculosis].
    Golli V, Stefanin E, Chiper P, Stefănescu I, Popescu-Crivina IM, Anghel E, Kosinski E, Daha A, Kosinski M, Floricel N.
    Ftiziologia; 1972 Jul; 21(5):489-94. PubMed ID: 4632131
    [No Abstract] [Full Text] [Related]

  • 3. [Ethambutol in the treatment of chronic pulmonary tuberculosis in patients excreting organisms resistant to several antitubercular agents].
    Bek-Lissner E, Rózewska M.
    Gruzlica; 1971 Jul; 39(7):643-7. PubMed ID: 5000656
    [No Abstract] [Full Text] [Related]

  • 4. [Ethambutol in the treatment of chronic pulmonary tuberculosis with bacilli resistant to tuberculostatics].
    Anastasatu C, Kaufman S, Barcan F, Gheorghiu M, Cristea M, Ulpian C, Iancovici O.
    Ftiziologia; 1971 Jul; 20(4):373-9. PubMed ID: 5005706
    [No Abstract] [Full Text] [Related]

  • 5. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A, Raafat H, Siddiqui GM.
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical and bacteriological experimentation with a new antitubercular chemotherapeutic agent: ethambutol].
    Serra C, Andreis G.
    G Ital Chemioter; 1966 Mar; 13(1):109-27. PubMed ID: 4967318
    [No Abstract] [Full Text] [Related]

  • 7. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S, Caugant DA, Sandven P, Mariandyshev AO, Bjune G.
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [Abstract] [Full Text] [Related]

  • 8. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK, Stead WW.
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract] [Full Text] [Related]

  • 9. [Refractory tuberculosis: concept and clinical cases].
    Sunahara S.
    Naika; 1971 Jun; 27(6):1358-63. PubMed ID: 4997127
    [No Abstract] [Full Text] [Related]

  • 10. Chemotherapy of chronic pulmonary tuberculosis with polyresistant bacteria with reference to ethambutol and capreomycin.
    Radenbach KL.
    Scand J Respir Dis Suppl; 1968 Jun; 65():195-206. PubMed ID: 4978461
    [No Abstract] [Full Text] [Related]

  • 11. [Therapeutic efficacy of the principal antitubercular drugs: an evaluation by antibiogram].
    Cremonte LG, Mantellini E.
    Minerva Med; 1989 Feb; 80(2):153-6. PubMed ID: 2494591
    [Abstract] [Full Text] [Related]

  • 12. Ethambutol in the re-treatment of multi-resistant advanced pulmonary tuberculosis (salvage cases).
    Roy DC, Sen PC, Bajpai BK.
    Indian J Chest Dis; 1974 Jul; 16(3):153-62. PubMed ID: 4422083
    [No Abstract] [Full Text] [Related]

  • 13. [Ethambutol monotherapy in chronic drug-resistant pulmonary tuberculosis].
    Ferraro U, Briccarello L, Vercellino E.
    G Ital Mal Torace; 1968 Jul; 22(4):195-201. PubMed ID: 5743001
    [No Abstract] [Full Text] [Related]

  • 14. [A study of prevalence of resistance to major drugs among newly admitted pulmonary tuberculosis patients in 1972. Part 2. Studies on the factors related to the prevalence of drug resistance (author's transl)].
    Gomi J, Chiba Y, Yanagisawa K.
    Kekkaku; 1975 Feb 15; 50(2):55-62. PubMed ID: 815707
    [No Abstract] [Full Text] [Related]

  • 15. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI, Terentieva AS.
    Probl Tuberk; 1981 Dec 15; (12):23-6. PubMed ID: 6801645
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI, Grishina TA, Karpenko OL, Safonova SG, Grishina TD.
    Probl Tuberk; 1995 Dec 15; (4):37-40. PubMed ID: 7567869
    [Abstract] [Full Text] [Related]

  • 18. [Monotherapy with ethambutol in chronic drug-resistant tuberculosis].
    Duchi G, Mostardini G, Palatresi R.
    Atti Accad Fisiocrit Siena Med Fis; 1967 Dec 15; 16(1):41-58. PubMed ID: 5621900
    [No Abstract] [Full Text] [Related]

  • 19. [Ethambutol in phthisiological experimentation and practice].
    Galassi A, Campanini A, Ciaccia A.
    G Ital Chemioter; 1966 Dec 15; 13(1):90-108. PubMed ID: 4967907
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.